FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102727282> ?p ?o ?g. }

• W2102727282 endingPage "169" @default.
• W2102727282 startingPage "163" @default.
• W2102727282 abstract "The aim of this review is to report our experience and the feasibility of neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer.Forty-five patients with primarily unresectable advanced-stage epithelial ovarian cancer were treated in our center between 1995 and 2002 by platinum-based neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy. Their files were reviewed retrospectively.At the end of neoadjuvant chemotherapy, according to RECIST criteria, 1 patient (2.2%) had achieved a clinical complete response (CR), 33 (73.4%) a partial response (PR), and 8 (17.8%) had stable disease (SD). Only 3 (6.6%) patients showed disease progression (PD). Surgery was performed in patients with objective response or SD after a median number of 4 courses (range: 2-6) of induction chemotherapy. A complete macroscopic debulking was achieved in 24 (53.3%) out of 39 patients in whom cytoreductive surgery was performed. For the entire group, median overall survival was 29 months. Survival was significantly improved in patients with optimal debulking compared to patients with persistent tumor after surgery: 41 months versus 23 months (P = 0.0062). Median survival for patients responding to neoadjuvant chemotherapy (CR and PR) was 44 months compared to 27 months for patients with SD or PD after initial chemotherapy (P = 0.01). Neither treatment-related deaths nor significant toxicities were observed.Neoadjuvant chemotherapy followed by optimal debulking may be a safe and valuable treatment alternative in patients with primarily unresectable advanced-stage bulky ovarian cancer. Patients with an objective response to chemotherapy or absence of macroscopic residual tumor after surgery have a better outcome. This approach is currently being tested in large, prospective randomized clinical trials." @default.
• W2102727282 created "2016-06-24" @default.
• W2102727282 creator A5003848425 @default.
• W2102727282 creator A5012878862 @default.
• W2102727282 creator A5018131884 @default.
• W2102727282 creator A5025060489 @default.
• W2102727282 creator A5027109717 @default.
• W2102727282 creator A5030556396 @default.
• W2102727282 creator A5049749170 @default.
• W2102727282 creator A5077529745 @default.
• W2102727282 creator A5085811948 @default.
• W2102727282 date "2003-07-01" @default.
• W2102727282 modified "2023-09-25" @default.
• W2102727282 title "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" @default.
• W2102727282 cites W1911903281 @default.
• W2102727282 cites W1935237200 @default.
• W2102727282 cites W1970283771 @default.
• W2102727282 cites W1973312028 @default.
• W2102727282 cites W1973834696 @default.
• W2102727282 cites W1974001298 @default.
• W2102727282 cites W1977958507 @default.
• W2102727282 cites W1982421876 @default.
• W2102727282 cites W2008344741 @default.
• W2102727282 cites W2010295336 @default.
• W2102727282 cites W2041306661 @default.
• W2102727282 cites W2053974737 @default.
• W2102727282 cites W2062101197 @default.
• W2102727282 cites W2096696139 @default.
• W2102727282 cites W2128524502 @default.
• W2102727282 cites W4233920089 @default.
• W2102727282 cites W4239451229 @default.
• W2102727282 cites W4250894715 @default.
• W2102727282 cites W4386008674 @default.
• W2102727282 doi "https://doi.org/10.1016/s0090-8258(03)00249-x" @default.
• W2102727282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12821358" @default.
• W2102727282 hasPublicationYear "2003" @default.
• W2102727282 type Work @default.
• W2102727282 sameAs 2102727282 @default.
• W2102727282 citedByCount "92" @default.
• W2102727282 countsByYear W21027272822012 @default.
• W2102727282 countsByYear W21027272822013 @default.
• W2102727282 countsByYear W21027272822014 @default.
• W2102727282 countsByYear W21027272822015 @default.
• W2102727282 countsByYear W21027272822016 @default.
• W2102727282 countsByYear W21027272822017 @default.
• W2102727282 countsByYear W21027272822018 @default.
• W2102727282 countsByYear W21027272822019 @default.
• W2102727282 countsByYear W21027272822020 @default.
• W2102727282 countsByYear W21027272822021 @default.
• W2102727282 countsByYear W21027272822022 @default.
• W2102727282 crossrefType "journal-article" @default.
• W2102727282 hasAuthorship W2102727282A5003848425 @default.
• W2102727282 hasAuthorship W2102727282A5012878862 @default.
• W2102727282 hasAuthorship W2102727282A5018131884 @default.
• W2102727282 hasAuthorship W2102727282A5025060489 @default.
• W2102727282 hasAuthorship W2102727282A5027109717 @default.
• W2102727282 hasAuthorship W2102727282A5030556396 @default.
• W2102727282 hasAuthorship W2102727282A5049749170 @default.
• W2102727282 hasAuthorship W2102727282A5077529745 @default.
• W2102727282 hasAuthorship W2102727282A5085811948 @default.
• W2102727282 hasConcept C121608353 @default.
• W2102727282 hasConcept C126322002 @default.
• W2102727282 hasConcept C141071460 @default.
• W2102727282 hasConcept C143998085 @default.
• W2102727282 hasConcept C146357865 @default.
• W2102727282 hasConcept C151730666 @default.
• W2102727282 hasConcept C2776694085 @default.
• W2102727282 hasConcept C2778822529 @default.
• W2102727282 hasConcept C2780427987 @default.
• W2102727282 hasConcept C2781100745 @default.
• W2102727282 hasConcept C71924100 @default.
• W2102727282 hasConcept C86803240 @default.
• W2102727282 hasConceptScore W2102727282C121608353 @default.
• W2102727282 hasConceptScore W2102727282C126322002 @default.
• W2102727282 hasConceptScore W2102727282C141071460 @default.
• W2102727282 hasConceptScore W2102727282C143998085 @default.
• W2102727282 hasConceptScore W2102727282C146357865 @default.
• W2102727282 hasConceptScore W2102727282C151730666 @default.
• W2102727282 hasConceptScore W2102727282C2776694085 @default.
• W2102727282 hasConceptScore W2102727282C2778822529 @default.
• W2102727282 hasConceptScore W2102727282C2780427987 @default.
• W2102727282 hasConceptScore W2102727282C2781100745 @default.
• W2102727282 hasConceptScore W2102727282C71924100 @default.
• W2102727282 hasConceptScore W2102727282C86803240 @default.
• W2102727282 hasIssue "1" @default.
• W2102727282 hasLocation W21027272821 @default.
• W2102727282 hasLocation W21027272822 @default.
• W2102727282 hasOpenAccess W2102727282 @default.
• W2102727282 hasPrimaryLocation W21027272821 @default.
• W2102727282 hasRelatedWork W167319750 @default.
• W2102727282 hasRelatedWork W2014690672 @default.
• W2102727282 hasRelatedWork W2065800215 @default.
• W2102727282 hasRelatedWork W2133480631 @default.
• W2102727282 hasRelatedWork W2581831974 @default.
• W2102727282 hasRelatedWork W2944256364 @default.
• W2102727282 hasRelatedWork W3097676887 @default.
• W2102727282 hasRelatedWork W4255034425 @default.
• W2102727282 hasRelatedWork W59268075 @default.

• next